160 related articles for article (PubMed ID: 7530506)
1. Myeloma cells express Fas antigen/APO-1 (CD95) but only some are sensitive to anti-Fas antibody resulting in apoptosis.
Shima Y; Nishimoto N; Ogata A; Fujii Y; Yoshizaki K; Kishimoto T
Blood; 1995 Feb; 85(3):757-64. PubMed ID: 7530506
[TBL] [Abstract][Full Text] [Related]
2. Expression and function of Fas (APO-1/CD95) in patient myeloma cells and myeloma cell lines.
Westendorf JJ; Lammert JM; Jelinek DF
Blood; 1995 Jun; 85(12):3566-76. PubMed ID: 7540067
[TBL] [Abstract][Full Text] [Related]
3. Flow cytometric analysis of cytokine receptors on human Langerhans' cells. Changes observed after short-term culture.
Larregina A; Morelli A; Kolkowski E; Fainboim L
Immunology; 1996 Feb; 87(2):317-25. PubMed ID: 8698397
[TBL] [Abstract][Full Text] [Related]
4. Expression of Fas/Apo-1 (CD95) and apoptosis in tumor cells from patients with plasma cell disorders.
Hata H; Matsuzaki H; Takeya M; Yoshida M; Sonoki T; Nagasaki A; Kuribayashi N; Kawano F; Takatsuki K
Blood; 1995 Sep; 86(5):1939-45. PubMed ID: 7544648
[TBL] [Abstract][Full Text] [Related]
5. Anti-Fas/APO-1 antibody-mediated apoptosis of cultured human glioma cells. Induction and modulation of sensitivity by cytokines.
Weller M; Frei K; Groscurth P; Krammer PH; Yonekawa Y; Fontana A
J Clin Invest; 1994 Sep; 94(3):954-64. PubMed ID: 7521890
[TBL] [Abstract][Full Text] [Related]
6. Functional consequences of APO-1/Fas (CD95) antigen expression by normal and neoplastic hematopoietic cells.
Robertson MJ; Manley TJ; Pichert G; Cameron C; Cochran KJ; Levine H; Ritz J
Leuk Lymphoma; 1995 Mar; 17(1-2):51-61. PubMed ID: 7539660
[TBL] [Abstract][Full Text] [Related]
7. All-trans retinoic acid modulates Fas antigen expression and affects cell proliferation and apoptosis in combination with anti-Fas monoclonal antibody in the human myeloma cell line, U266B1.
Okamura T; Masuda M; Arai Y; Ishida C; Shudou K; Mizoguchi H
Exp Hematol; 1998 Jun; 26(6):501-6. PubMed ID: 9620283
[TBL] [Abstract][Full Text] [Related]
8. Pattern of cytokine receptors expressed by human dendritic cells migrated from dermal explants.
Larregina AT; Morelli AE; Kolkowski E; Sanjuan N; Barboza ME; Fainboim L
Immunology; 1997 Jun; 91(2):303-13. PubMed ID: 9227332
[TBL] [Abstract][Full Text] [Related]
9. CD40 ligand-induced apoptosis is Fas-independent in human multiple myeloma cells.
Tong AW; Seamour B; Chen J; Su D; Ordonez G; Frase L; Netto G; Stone MJ
Leuk Lymphoma; 2000 Feb; 36(5-6):543-58. PubMed ID: 10784400
[TBL] [Abstract][Full Text] [Related]
10. Expression of Apo-1/Fas (CD95), Bcl-2, Bax and Bcl-x in myeloma cell lines: relationship between responsiveness to anti-Fas mab and p53 functional status.
Egle A; Villunger A; Marschitz I; Kos M; Hittmair A; Lukas P; Grünewald K; Greil R
Br J Haematol; 1997 May; 97(2):418-28. PubMed ID: 9163609
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-6 inhibits Fas-induced apoptosis and stress-activated protein kinase activation in multiple myeloma cells.
Chauhan D; Kharbanda S; Ogata A; Urashima M; Teoh G; Robertson M; Kufe DW; Anderson KC
Blood; 1997 Jan; 89(1):227-34. PubMed ID: 8978296
[TBL] [Abstract][Full Text] [Related]
12. Interferon gamma and tumor necrosis factor alpha induce Fas expression and anti-Fas mediated apoptosis in a salivary ductal cell line.
Matsumura R; Umemiya K; Goto T; Nakazawa T; Ochiai K; Kagami M; Tomioka H; Tanabe E; Sugiyama T; Sueishi M
Clin Exp Rheumatol; 2000; 18(3):311-8. PubMed ID: 10895367
[TBL] [Abstract][Full Text] [Related]
13. Modulation of Apo-1/Fas (CD95)-induced programmed cell death in myeloma cells by interferon-alpha 2.
Egle A; Villunger A; Kos M; Böck G; Gruber J; Auer B; Greil R
Eur J Immunol; 1996 Dec; 26(12):3119-26. PubMed ID: 8977313
[TBL] [Abstract][Full Text] [Related]
14. Analysis of cytokine receptor messenger RNA expression in human glioblastoma cells and normal astrocytes by reverse-transcription polymerase chain reaction.
Tada M; Diserens AC; Desbaillets I; de Tribolet N
J Neurosurg; 1994 Jun; 80(6):1063-73. PubMed ID: 7514661
[TBL] [Abstract][Full Text] [Related]
15. Expression and production of interleukin 10 in human myeloma cell lines.
Otsuki T; Yamada O; Yata K; Sakaguchi H; Kurebayashi J; Yawata Y; Ueki A
Br J Haematol; 2000 Dec; 111(3):835-42. PubMed ID: 11122145
[TBL] [Abstract][Full Text] [Related]
16. Fas antigen/APO-1 (CD95) expression on myeloma cells.
Shima Y; Nishimoto N; Yoshizaki K; Kishimoto T
Leuk Lymphoma; 1996 Nov; 23(5-6):521-31. PubMed ID: 9031082
[TBL] [Abstract][Full Text] [Related]
17. Effects of combined antigrowth factor receptor treatment on in vitro growth of multiple myeloma.
Taetle R; Dos Santos B; Ohsugi Y; Koishihara Y; Yamada Y; Messner H; Dalton W
J Natl Cancer Inst; 1994 Mar; 86(6):450-5. PubMed ID: 8120920
[TBL] [Abstract][Full Text] [Related]
18. Effects of all-trans retinoic acid and antireceptor antibodies on growth and programmed cell death of human myeloma cells.
Taetle R; Dos Santos B; Akamatsu K; Koishihara Y; Ohsugi Y
Clin Cancer Res; 1996 Feb; 2(2):253-9. PubMed ID: 9816167
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of bcl-2 and susceptibility to anti-Fas-mediated cell death in peripheral blood lymphocytes, monocytes, and neutrophils.
Iwai K; Miyawaki T; Takizawa T; Konno A; Ohta K; Yachie A; Seki H; Taniguchi N
Blood; 1994 Aug; 84(4):1201-8. PubMed ID: 7519477
[TBL] [Abstract][Full Text] [Related]
20. On the role and significance of Fas (Apo-1/CD95) ligand (FasL) expression in immune privileged tissues and cancer cells using multiple myeloma as a model.
Greil R; Egle A; Villunger A
Leuk Lymphoma; 1998 Nov; 31(5-6):477-90. PubMed ID: 9922038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
